TY - JOUR
T1 - Disruption of neurogenesis and cortical development in transgenic mice misexpressing Olig2, a gene in the Down syndrome critical region
AU - Liu, Wei
AU - Zhou, Hui
AU - Liu, Lei
AU - Zhao, Chuntao
AU - Deng, Yaqi
AU - Chen, Lina
AU - Wu, Laiman
AU - Mandrycky, Nicole
AU - McNabb, Christopher T.
AU - Peng, Yuanbo
AU - Fuchs, Perry N.
AU - Lu, Jie
AU - Sheen, Volney
AU - Qiu, Mengsheng
AU - Mao, Meng
AU - Richard Lu, Q.
N1 - Funding Information:
The authors thank Yuji Mishina for providing the transgenic vector. This study was funded in part by grants from the US National Institutes of Health ( R01NS072427 and R01NS075243 ) and the National Multiple Sclerosis Society ( RG3978 ) to QRL, and the National Natural Science Foundation of China , grant nos. 81170607 and 81200461 to HZ and LC.
Publisher Copyright:
© 2015 Elsevier Inc.
PY - 2015/5/1
Y1 - 2015/5/1
N2 - The basic helix-loop-helix (bHLH) transcription factor Olig2 is crucial for mammalian central nervous system development. Human ortholog OLIG2 is located in the Down syndrome critical region in trisomy 21. To investigate the effect of Olig2 misexpression on brain development, we generated a developmentally regulated Olig2-overexpressing transgenic line with a Cre/loxP system. The transgenic mice with Olig2 misexpression in cortical neural stem/progenitor cells exhibited microcephaly, cortical dyslamination, hippocampus malformation, and profound motor deficits. Ectopic misexpression of Olig2 impaired cortical progenitor proliferation and caused precocious cell cycle exit. Massive neuronal cell death was detected in the developing cortex of Olig2-misexpressing mice. In addition, Olig2 misexpression led to a significant downregulation of neuronal specification factors including Ngn1, Ngn2 and Pax6, and a defect in cortical neurogenesis. Chromatin-immunoprecipitation and sequencing (ChIP-Seq) analysis indicates that Olig2 directly targets the promoter and/or enhancer regions of Nfatc4, Dscr1/Rcan1 and Dyrk1a, the critical neurogenic genes that contribute to Down syndrome phenotypes, and inhibits their expression. Together, our study suggests that Olig2 misexpression in neural stem cells elicits neurogenesis defects and neuronal cell death, which may contribute to developmental disorders including Down syndrome, where OLIG2 is triplicated on chromosomal 21.
AB - The basic helix-loop-helix (bHLH) transcription factor Olig2 is crucial for mammalian central nervous system development. Human ortholog OLIG2 is located in the Down syndrome critical region in trisomy 21. To investigate the effect of Olig2 misexpression on brain development, we generated a developmentally regulated Olig2-overexpressing transgenic line with a Cre/loxP system. The transgenic mice with Olig2 misexpression in cortical neural stem/progenitor cells exhibited microcephaly, cortical dyslamination, hippocampus malformation, and profound motor deficits. Ectopic misexpression of Olig2 impaired cortical progenitor proliferation and caused precocious cell cycle exit. Massive neuronal cell death was detected in the developing cortex of Olig2-misexpressing mice. In addition, Olig2 misexpression led to a significant downregulation of neuronal specification factors including Ngn1, Ngn2 and Pax6, and a defect in cortical neurogenesis. Chromatin-immunoprecipitation and sequencing (ChIP-Seq) analysis indicates that Olig2 directly targets the promoter and/or enhancer regions of Nfatc4, Dscr1/Rcan1 and Dyrk1a, the critical neurogenic genes that contribute to Down syndrome phenotypes, and inhibits their expression. Together, our study suggests that Olig2 misexpression in neural stem cells elicits neurogenesis defects and neuronal cell death, which may contribute to developmental disorders including Down syndrome, where OLIG2 is triplicated on chromosomal 21.
KW - Cortical development
KW - Cortical progenitor proliferation
KW - Down syndrome
KW - Neural cell death
KW - Neurogenesis
KW - Olig2
UR - http://www.scopus.com/inward/record.url?scp=84925016766&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84925016766&partnerID=8YFLogxK
U2 - 10.1016/j.nbd.2015.02.021
DO - 10.1016/j.nbd.2015.02.021
M3 - Article
C2 - 25747816
AN - SCOPUS:84925016766
SN - 0969-9961
VL - 77
SP - 106
EP - 116
JO - Neurobiology of Disease
JF - Neurobiology of Disease
ER -